The estimated Net Worth of Bruce G. Bodaken is at least $2.6 Million dollars as of 18 May 2020. Mr. Bodaken owns over 3,003 units of Rite Aid stock worth over $2,344 and over the last 12 years he sold RAD stock worth over $2,274,558. In addition, he makes $319,966 as Independent Chairman of the Board at Rite Aid.
Sign up
Mr. Bodaken RAD stock SEC Form 4 insiders trading
Bruce has made over 10 trades of the Rite Aid stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 3,003 units of RAD stock worth $394,955 on 18 May 2020.
The largest trade he's ever made was selling 61,500 units of Rite Aid stock on 12 June 2013 worth over $1,826,550. On average, Bruce trades about 3,020 units every 70 days since 2013. As of 18 May 2020 he still owns at least 3,606 units of Rite Aid stock.
You can see the complete history of Mr. Bodaken stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Bruce Bodaken biography
Bruce G. Bodaken serves as Independent Chairman of the Board of the Company effective Oct. 30, 2018. From 2000 through December 2012, Mr. Bodaken served as Chairman and Chief Executive Officer of Blue Shield of California. Mr. Bodaken also previously served as President and Chief Operating Officer of Blue Shield of California from 1995 to 2000 and Executive Vice President and Chief Operating Officer from 1994 to 1995. Prior to joining Blue Shield of California, Mr. Bodaken served as Senior Vice President and Associate Chief Operating Officer of F.H.P., Inc., a managed care provider, from 1990 to 1994 and held various positions at F.H.P. from 1980 to 1990, including Regional Vice President. Mr. Bodaken is currently a director and a member of the audit committee of WageWorks, Inc. He also has a Visiting Scholar appointment at the Brookings Institution and is a Visiting Lecturer in the Department of Public Health at UC Berkeley.
What is the salary of Bruce Bodaken?
As the Independent Chairman of the Board of Rite Aid, the total compensation of Bruce Bodaken at Rite Aid is $319,966. There are 9 executives at Rite Aid getting paid more, with Heyward Donigan having the highest compensation of $8,619,340.
How old is Bruce Bodaken?
Bruce Bodaken is 68, he's been the Independent Chairman of the Board of Rite Aid since 2018. There are 1 older and 17 younger executives at Rite Aid. The oldest executive at Rite Aid Corp. is Arun Nayar, 69, who is the Independent Director.
What's Bruce Bodaken's mailing address?
Bruce's mailing address filed with the SEC is C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO, CA, 94103.
Insiders trading at Rite Aid
Over the last 45 years, insiders at Rite Aid have traded over $704,219,544 worth of Rite Aid stock and bought 1,989,612 units worth $9,286,101 . The most active insiders traders include Coutu Group (Pjc) Inc. Jean, John M Baumer, and Equity Investors Iii Lpgei .... On average, Rite Aid executives and independent directors trade stock every 238 days with the average trade being worth of $2,811,488. The most recent stock trade was executed by Heyward R Donigan on 22 December 2021, trading 14,350 units of RAD stock currently worth $199,896.
What does Rite Aid do?
riteaid is a company based out of 7189 henry clay blvd, liverpool, new york, united states.
What does Rite Aid's logo look like?
Complete history of Mr. Bodaken stock trades at iRhythm Technologies Inc and Rite Aid
Rite Aid executives and stock owners
Rite Aid executives and other stock owners filed with the SEC include:
-
Heyward Donigan,
President, Chief Executive Officer, Director -
Heyward Rutledge Donigan B.A.,
Pres CEO & Director -
Jocelyn Konrad,
Executive Vice President - Pharmacy and Retail Operations -
Matthew Schroeder,
Chief Financial Officer, Senior Vice President -
James Peters,
Chief Operating Officer -
Jocelyn Zazyczny Konrad,
Exec. VP & Chief Pharmacy Officer -
James Joseph Peters Jr.,
Chief Operating Officer -
Matthew C. Schroeder,
CFO & Exec. VP -
Justin L. Mennen,
Exec. VP & Chief Information Officer -
Bruce Bodaken,
Independent Chairman of the Board -
Louis Miramontes,
Independent Director -
Arun Nayar,
Independent Director -
Kevin Lofton,
Independent Director -
Robert Knowling,
Independent Director -
Marcy Syms,
Independent Director -
Elizabeth Burr,
Independent Director -
Katherine Quinn,
Independent Director -
Bari Harlam,
Independent Director -
Paul Gilbert,
General Counsel, Company Secretary -
Brian Hoover,
Chief Accounting Officer -
Roxanne Schwans,
Senior Vice President - Market Access and Pharmacy Purchasing -
Angele Robinson-Gaylord,
Senior Vice President - Store Development -
Chris Bohrer,
Senior Vice President - Payor and Strategic Initiatives -
Trent Kruse,
Senior Vice President of Investor Relations, Treasury -
Erik Keptner,
Senior Vice President, Chief Marketing Officer -
Justin Mennen,
Senior Vice President, Chief Information Officer -
Andre Persaud,
Executive Vice President - Retail -
Susan K. Henderson,
Chief Communications Officer & Sr. VP -
Paul D. Gilbert,
Exec. VP, Gen. Counsel & Corp. Sec. -
Byron Purcell,
Sr. Director of Treasury Services & Investor Relations -
Brian T. Hoover,
Chief Accounting Officer & Sr. VP -
Michel Coutu,
Director -
James Donald,
Director -
Steven Bixler,
Chief Accounting Officer -
Bryan B Everett,
CHIEF OPERATING OFFICER -
Frank A Savage,
Director -
Michael N Regan,
Director -
Myrtle S Potter,
Director -
Joseph B Jr Anderson,
Director -
Castle Dedra Newman,
EVP -
David Jessick,
Director -
John T Standley,
Senior EVP & CAO -
David Abelman,
EVP -
Tony Montini,
EVP -
Darren W Karst,
EVP & CFO -
Kermit R Crawford,
President and COO -
Jessica Kazmaier,
EVP, Chief HR Officer -
James J Comitale,
EVP, General Counsel, Secy. -
Matt Schroeder,
EVP, Chief Financial Officer -
Derek S. Griffith,
Field EVP, Store Operations -
Benjamin Bulkley,
CEO EnvisionRXOptions -
Kenneth Martindale,
Senior Executive VP -
Andre Belzile,
Director -
Dennis Wood,
Director -
Philip G Satre,
Director -
Robert Gerald Miller,
Director -
Pierre Legault,
Senior EVP - CAO -
Equity Investors Iii Lpgree...,
-
Stuart M Sloan,
Director -
Douglas E Donley,
Senior VP and CAO -
Colin V Reed,
Director -
Robert Sari,
SVP AND GENERAL COUNSEL and -
Michael A Friedman,
Director -
Jonathan Ddanhakl John G So...,
-
George Golleher,
Director -
Robert J Easley,
Chief Operating Officer -
Mary F Sammons,
PRESIDENT & CEO -
Bruin Jerry Mark De,
EVP, Pharmacy -
Mark C Panzer,
SR. EVP - Store Operations -
Alfred Gleason,
Director -
Equity Investors Iii Lpgree...,
-
Kevin Twomey,
SVP & CHIEF ACCOUNTING OFFICER -
Robert A Mariano,
Director -
James P Mastrian,
SR.EVP.- Category Management -
Christopher Hall,
EVP and CFO -
Robert K Thompson,
EVP -
Robert Ivan Thompson,
EVP - Pharmacy -
Frank Vitrano,
Chief Admin. Officer & CFO -
Marc A Strassler,
EVP,General Counsel -
Coutu Group (Pjc) Inc. Jean,
10% owner -
Brian Fiala,
Executive VP, Operations -
Equity Investors Iii Lpgei ...,
-
John M Baumer,
Director -
Francois J Coutu,
Director -
Dan Robson,
President, EnvisionRXOptions -
Ray Smithberger,
SVP, Operations